Skip to main content
High RiskFDAfda-F-0877-2017UNDECLARED ALLERGEN

the Peanut Principle, Dashing Thru the Dough, Gourmet Chocolate Chip Cookie Dough Peanut Butter, NET WT 16oz, UPC 609207898788

Category
Units Affected
900
Recall Date
December 21, 2016
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0877-2017.

Presence of undeclared soy lecithin

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0877-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Capitol City Specialties Company or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0877-2017.

Capitol City Specialties Company

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Capitol City Specialties Company Recall FAQ

Capitol City Specialties Company is the subject of a dairy safety report: the Peanut Principle, Dashing Thru the Dough, Gourmet Chocolate Chip Cookie Dough Peanut Butter, NET WT 16oz, UPC 609207898788. The notice was published on December 21, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 900 units are potentially affected.